A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors

The requested reference [dad7e44da6af212dea959801e6b64b5cc6980c2f] no longer exists in our database. It has been replaced by the current reference: [4262e9377fe36e531703a7bc975649e1c1359b9b]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Phase I/IIa clinical study SGT003 in patients with advanced solid tumors.
Epistemonikos ID: d3e6eee1da713b3a98805256b9115bdc9d5cda69
First added on: Sep 10, 2026